Australia markets closed

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
22.48+1.63 (+7.82%)
At close: 04:00PM EDT
22.69 +0.21 (+0.93%)
Pre-market: 08:31AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
55,904
140,517
232,694
297,098
-
Other short-term investments
317,271
215,877
156,046
185,621
-
Total cash
373,175
356,394
388,740
482,719
-
Other current assets
5,047
7,666
3,319
4,626
-
Total current assets
378,222
364,060
392,059
487,345
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
101,622
86,738
77,571
72,687
-
Accumulated depreciation
-14,032
-9,093
-5,223
-2,046
-
Net property, plant and equipment
87,590
77,645
72,348
70,641
-
Equity and other investments
34,320
43,276
0
-
0
Goodwill
39,154
39,154
30,815
30,815
-
Intangible assets
25,150
25,724
-
-
226
Other long-term assets
1,372
1,340
1,343
1,568
-
Total non-current assets
188,119
187,747
104,961
103,479
-
Total assets
566,341
551,807
497,020
590,824
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
4,875
-
Accrued liabilities
22,722
26,057
14,485
20,007
-
Deferred revenues
-
-
-
590
562
Total current liabilities
48,505
39,169
22,167
32,617
-
Non-current liabilities
Long-term debt
-
-
-
35,066
45,049
Other long-term liabilities
2,936
2,595
80
136
-
Total non-current liabilities
25,262
22,952
20,129
54,688
-
Total liabilities
73,767
62,121
42,296
87,305
-
Stockholders' equity
Common stock
903
791
645
610
-
Retained earnings
-959,370
-713,775
-491,912
-322,843
-
Accumulated other comprehensive income
319
-357
-161
-42
-
Total stockholders' equity
492,574
489,686
454,724
503,519
-
Total liabilities and stockholders' equity
566,341
551,807
497,020
590,824
-